isatin has been researched along with Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glover, V; Sandler, M; Stern, GM; Stibbe, K; Ueki, A; Willoughby, J | 1 |
| Clow, A; Elwes, R; Glover, V; Reynolds, EH; Sandler, M | 1 |
2 other study(ies) available for isatin and Nervous System Diseases
| Article | Year |
|---|---|
Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson's disease and other neurological disorders.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Female; Humans; Isatin; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nervous System Diseases; Parkinson Disease | 1989 |
Tribulin output in neurological disorders.
Topics: Epilepsy; Humans; Isatin; Monoamine Oxidase Inhibitors; Nervous System Diseases | 1987 |